These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 25536409)

  • 1. Spectral overlap-free quantum dot-based determination of benzo[a]pyrene-induced cancer stem cells by concurrent monitoring of CD44, CD24 and aldehyde dehydrogenase 1.
    Shim Y; Song JM
    Chem Commun (Camb); 2015 Feb; 51(11):2118-21. PubMed ID: 25536409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
    Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
    J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.
    de Beça FF; Caetano P; Gerhard R; Alvarenga CA; Gomes M; Paredes J; Schmitt F
    J Clin Pathol; 2013 Mar; 66(3):187-91. PubMed ID: 23112116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome.
    Hashimoto K; Shimizu C; Tsuda H; Saji S; Osaki A; Shigekawa T; Aogi K
    Oncology; 2012; 82(3):168-74. PubMed ID: 22433454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
    Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk-eliminated quantitative determination of aflatoxin B1-induced hepatocellular cancer stem cells based on concurrent monitoring of CD133, CD44, and aldehyde dehydrogenase1.
    Ju H; Shim Y; Arumugam P; Song JM
    Toxicol Lett; 2016 Jan; 243():31-9. PubMed ID: 26739636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of sphere‑forming cells with stem‑like properties from the gastric cancer cell lines MKN45 and SGC7901.
    Wang X; Zou F; Deng H; Fu Z; Li Y; Wu L; Wang Z; Liu L
    Mol Med Rep; 2014 Dec; 10(6):2937-41. PubMed ID: 25270642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristic genes in luminal subtype breast tumors with CD44+CD24-/low gene expression signature.
    Tsunoda Y; Sakamoto M; Sawada T; Sasaki A; Yamamoto G; Tachikawa T
    Oncology; 2011; 81(5-6):336-44. PubMed ID: 22237177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cell dissociation on identification of breast cancer stem cells.
    Quan Y; Yan Y; Wang X; Fu Q; Wang W; Wu J; Yang G; Ren J; Wang Y
    Cancer Biomark; 2012-2013; 12(3):125-33. PubMed ID: 23481571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer stem cells and intrinsic subtypes: controversies rage on.
    Nakshatri H; Srour EF; Badve S
    Curr Stem Cell Res Ther; 2009 Jan; 4(1):50-60. PubMed ID: 19149630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.
    Gudadze M; Kankava Q; Mariamidze A; Burkadze G
    Georgian Med News; 2014 Mar; (228):81-7. PubMed ID: 24743129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases.
    Horimoto Y; Arakawa A; Sasahara N; Tanabe M; Sai S; Himuro T; Saito M
    PLoS One; 2016; 11(10):e0165253. PubMed ID: 27768764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of CD44+/CD24-/low breast cancer stem/progenitor cells to tamoxifen‑ and doxorubicin‑induced autophagy.
    Yenigun VB; Ozpolat B; Kose GT
    Int J Mol Med; 2013 Jun; 31(6):1477-83. PubMed ID: 23589132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of CD44/CD24 positive cells in ductal invasive carcinoma of breast of different grade and molecular subtype.
    Gudadze M; Kankava K; Mariamidze A; Mosidze T; Burkadze G
    Georgian Med News; 2013 Sep; (222):50-7. PubMed ID: 24099815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44(+)/CD24(-) cells are transit progenitors and do not determine the molecular subtypes and clinical parameters in breast carcinomas.
    Lü X; Xu K; Lü H; Yin Y; Ma C; Liu Y; Li H; Suo Z
    Ultrastruct Pathol; 2011 Apr; 35(2):72-8. PubMed ID: 21299347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress of research on breast cancer stem cell markers].
    Liu X; Li W; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):282-4. PubMed ID: 24915825
    [No Abstract]   [Full Text] [Related]  

  • 18. ALDH(+)/CD44(+)/CD24(-) expression in cells from body cavity fluids.
    Krishan A; Sharma D; Sharma S; Hamelik RM; Ganjei-Azar P; Nadji M
    Cytometry B Clin Cytom; 2010 May; 78(3):176-82. PubMed ID: 20043317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advancement of studies on ALDH1 as a universal marker of stem cells].
    Han M; Wu C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Oct; 27(5):1183-6. PubMed ID: 21089696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for breast cancer stem cells: the challenges ahead.
    Gökmen-Polar Y; Nakshatri H; Badve S
    Biomark Med; 2011 Oct; 5(5):661-71. PubMed ID: 22003917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.